Molecular Templates (MTEM) Short Interest Ratio & Short Volume $0.0005 0.00 (0.00%) As of 01:01 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends Molecular Templates Short Interest DataMolecular Templates (MTEM) has a short interest of 298,000 shares, representing 5.48% of the float (the number of shares available for trading by the public). This marks a 41.30% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 102,565 shares to cover all short positions.Current Short Interest298,000 sharesPrevious Short Interest210,900 sharesChange Vs. Previous Month+41.30%Dollar Volume Sold Short$119,200.00Short Interest Ratio0.0 Days to CoverLast Record DateDecember 15, 2024Outstanding Shares6,580,000 sharesFloat Size5,440,000 sharesShort Percent of Float5.48%Today's Trading Volume6,717 sharesAverage Trading Volume102,565 sharesToday's Volume Vs. Average7% Short Selling Molecular Templates? Sign up to receive the latest short interest report for Molecular Templates and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMTEM Short Interest Over TimeMTEM Days to Cover Over TimeMTEM Percentage of Float Shorted Over Time Molecular Templates Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/15/2024298,000 shares $119,200.00 +41.3%5.5%0 $0.40 11/30/2024210,900 shares $78,054.09 -91.4%3.9%0 $0.37 11/15/20242,460,000 shares $1.15 million +810.8%45.2%0.2 $0.47 10/31/2024270,100 shares $121,545.00 +7.4%5.0%0.1 $0.45 10/15/2024251,400 shares $84,948.06 +77.2%4.6%0.1 $0.34 9/30/2024141,900 shares $199,369.50 -25.4%2.6%5 $1.41 9/15/2024190,100 shares $226,238.01 +6.0%3.5%6.7 $1.19 8/31/2024179,300 shares $274,329.00 +2.2%3.3%6.1 $1.53 8/15/2024175,500 shares $261,495.00 +42.2%3.2%5 $1.49 7/31/2024123,400 shares $186,334.00 -5.5%3.0%3.2 $1.51 Get the Latest News and Ratings for MTEM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Molecular Templates and its competitors with MarketBeat's FREE daily newsletter. 7/15/2024130,600 shares $184,146.00 +2.0%3.1%3 $1.41 6/30/2024128,000 shares $147,200.00 -30.7%3.1%1.6 $1.15 6/15/2024184,800 shares $241,164.00 -7.7%4.4%2.1 $1.31 5/31/2024200,300 shares $244,366.00 +51.6%5.6%2.3 $1.22 5/15/2024132,100 shares $191,545.00 -21.9%3.7%1.7 $1.45 4/30/2024169,100 shares $277,324.00 -17.8%4.7%2.5 $1.64 4/15/2024205,600 shares $365,968.00 +508.3%7.0%3.3 $1.78 3/31/202433,800 shares $75,712.00 +23.8%1.2%0.6 $2.24 3/15/202427,300 shares $75,075.00 -29.8%0.6%1.8 $2.75 2/29/202438,900 shares $149,765.00 -31.4%0.9%3.6 $3.85 2/15/202456,700 shares $205,254.00 -9.6%1.3%6.3 $3.62 1/31/202462,700 shares $220,077.00 +6.3%1.4%6.7 $3.51 1/15/202459,000 shares $212,400.00 -9.0%1.4%6.2 $3.60 12/31/202364,800 shares $241,704.00 +76.1%1.5%6.8 $3.73 12/15/202336,800 shares $134,688.00 -45.1%0.8%4.2 $3.66 11/30/202367,000 shares $326,960.00 -0.5%1.5%8 $4.88 11/15/202367,300 shares $351,306.00 +2.0%1.5%8.4 $5.22 10/31/202366,000 shares $363,000.00 +11.5%1.5%7.3 $5.50 10/15/202359,200 shares $377,790.72 +1.7%1.4%6.1 $6.38 9/30/202358,200 shares $367,824.00 -6.9%1.3%3.8 $6.32 9/15/202362,500 shares $428,750.00 +9.3%1.4%4.2 $6.86 8/31/202357,200 shares $486,772.00 -39.9%1.3%4 $8.51 8/15/202395,100 shares $789,330.00 -88.3%2.2%6.3 $8.30 7/31/2023809,600 shares $486,569.60 -17.5%N/A3.9 $0.60 7/15/2023981,100 shares $483,682.30 +3.8%N/A5.3 $0.49 6/30/2023945,100 shares $453,648.00 -12.5%2.1%8.3 $0.48 6/15/20231,080,000 shares $539,892.00 +1.9%2.4%7 $0.50 5/31/20231,060,000 shares $498,200.00 +1.9%2.3%1.4 $0.47 5/15/20231,040,000 shares $436,800.00 -14.8%2.3%1.4 $0.42 4/30/20231,220,000 shares $479,338.00 -12.9%2.7%1.6 $0.39Critical ‘Buy Now’ Alert on My Favorite Stock! (Ad)My absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> 4/15/20231,400,000 shares $658,000.00 +40.0%3.1%1.8 $0.47 3/31/20231,000,000 shares $379,900.00 -5.7%2.3%1.3 $0.38 3/15/20231,060,000 shares $349,906.00 +187.2%2.5%1.4 $0.33 2/28/2023369,100 shares $173,477.00 +27.2%0.9%2.7 $0.47 2/15/2023290,200 shares $139,644.24 -15.9%0.7%1.8 $0.48 1/31/2023345,100 shares $186,008.90 +5.5%0.8%2.1 $0.54 1/15/2023327,200 shares $150,577.44 -6.3%0.7%2.1 $0.46 12/30/2022349,000 shares $114,472.00 -17.7%0.8%2.3 $0.33 12/15/2022423,900 shares $190,755.00 -4.4%1.0%3.2 $0.45 11/30/2022443,500 shares $235,010.65 +3.4%1.0%3.6 $0.53 11/15/2022429,100 shares $272,735.96 -19.6%1.0%4.1 $0.64 10/31/2022533,500 shares $316,952.35 +1.0%1.2%5.4 $0.59 10/15/2022528,100 shares $343,159.38 +7.4%1.3%4.8 $0.65 9/30/2022491,800 shares $368,702.46 -6.9%1.2%4.2 $0.75 9/15/2022528,100 shares $417,938.34 +40.1%1.3%2.5 $0.79 8/31/2022376,900 shares $276,531.53 +18.0%0.9%1.6 $0.73 8/15/2022319,300 shares $309,273.98 +1.5%0.8%1.2 $0.97 7/31/2022314,700 shares $264,977.40 -1.6%0.8%1.1 $0.84 7/15/2022319,800 shares $332,592.00 -32.6%0.8%1 $1.04 6/30/2022474,700 shares $432,736.52 -68.8%1.1%1.4 $0.91 6/15/20221,520,000 shares $1.33 million -2.6%3.6%4.4 $0.87 5/31/20221,560,000 shares $1.54 million +2.0%3.7%6.3 $0.99 5/15/20221,530,000 shares $1.90 million +8.5%3.7%7.2 $1.24 4/30/20221,410,000 shares $2.40 million +24.8%3.4%7.3 $1.70 4/15/20221,130,000 shares $2.86 million +6.6%2.7%6 $2.53 3/31/20221,060,000 shares $3.66 million +2.9%2.5%5.9 $3.45 3/15/20221,030,000 shares $2.42 million +30.9%2.5%4.5 $2.35 2/28/2022786,600 shares $1.85 million +13.1%1.9%3.2 $2.35 2/15/2022695,400 shares $1.93 million +17.2%1.7%2.5 $2.77 1/31/2022593,600 shares $1.83 million +1.3%1.5%2 $3.08 1/15/2022586,200 shares $2.17 million +5.4%1.4%2 $3.70 12/31/2021556,400 shares $2.18 million +2.7%1.3%1.9 $3.92 12/15/2021542,000 shares $1.99 million -11.7%1.3%1.9 $3.67 11/30/2021613,800 shares $2.46 million +1.6%1.5%1.9 $4.01 11/15/2021604,000 shares $3.25 million -9.9%1.5%2 $5.38 10/29/2021670,100 shares $3.50 million -1.0%1.6%2.4 $5.22 10/15/2021676,900 shares $4.29 million -49.1%1.6%2.5 $6.34 9/30/20211,330,000 shares $8.92 million No Change3.2%4.6 $6.71 9/15/20211,330,000 shares $8.07 million +2.3%3.2%5 $6.07 8/31/20211,300,000 shares $8.48 million -16.1%3.2%6.4 $6.52 8/13/20211,550,000 shares $11.78 million -5.5%3.8%7.1 $7.60 7/30/20211,640,000 shares $11.48 million +4.5%4.0%6.9 $7.00 7/15/20211,570,000 shares $10.80 million +0.6%3.9%5.8 $6.88 6/30/20211,560,000 shares $12.20 million +8.3%3.8%4.9 $7.82 6/15/20211,440,000 shares $12.43 million -1.4%3.5%3.4 $8.63 5/28/20211,460,000 shares $13.05 million +4.3%3.6%3.5 $8.94 5/14/20211,400,000 shares $11.68 million -11.4%N/A3.1 $8.34 4/30/20211,580,000 shares $14.79 million -7.1%N/A3.2 $9.36 4/15/20211,700,000 shares $14.03 million +37.1%8.8%3.4 $8.25 3/31/20211,240,000 shares $14.38 million +11.7%N/A2.7 $11.60Critical ‘Buy Now’ Alert on My Favorite Stock! (Ad)My absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> 3/15/20211,110,000 shares $13.00 million +5.7%N/A3.1 $11.71 2/26/20211,050,000 shares $11.57 million -11.8%N/A2.6 $11.02 2/12/20211,190,000 shares $16.58 million -2.5%N/A2.9 $13.93 1/29/20211,220,000 shares $13.83 million No Change3.4%2.9 $11.34 1/15/20211,220,000 shares $13.53 million -11.6%3.4%2.9 $11.09 12/31/20201,380,000 shares $13.08 million -21.1%3.8%3.5 $9.48 12/15/20201,750,000 shares $17.97 million -14.2%4.8%4.5 $10.27 11/30/20202,040,000 shares $18.60 million +7.4%5.6%5.2 $9.12 11/15/20201,900,000 shares $19.51 million +2.2%5.2%4.9 $10.27 10/30/20201,860,000 shares $17.67 million +14.1%5.1%5.2 $9.50 10/15/20201,630,000 shares $19.19 million +13.2%4.5%5.2 $11.77 9/30/20201,440,000 shares $15.72 million +48.5%4.0%3.6 $10.92 9/15/2020969,500 shares $12.75 million +4.6%2.7%2.2 $13.15 8/31/2020927,300 shares $10.77 million -3.9%2.6%2.3 $11.61 8/14/2020965,000 shares $11.22 million -38.9%2.8%2.3 $11.63 7/31/20201,580,000 shares $17.33 million -3.7%4.6%3.5 $10.97 7/15/20201,640,000 shares $20.02 million +2.5%5.5%3.8 $12.21 6/30/20201,600,000 shares $22.06 million +40.4%5.3%4.5 $13.79 6/15/20201,140,000 shares $17.29 million -5.0%3.8%3.7 $15.17 5/29/20201,200,000 shares $18.52 million -8.4%4.0%4 $15.43 5/15/20201,310,000 shares $21.03 million -6.4%4.5%4.5 $16.05 4/30/20201,400,000 shares $23.70 million -4.8%4.6%5.3 $16.93 4/15/20201,470,000 shares $23.28 million -13.5%5.3%5.3 $15.84 3/31/20201,700,000 shares $28.90 million -5.9%6.1%5.8 $17.00 3/13/20201,806,900 shares $27.21 million +39.0%7.0%6.7 $15.06 2/28/20201,300,000 shares $16.03 million +9.2%5.0%3.8 $12.33 MTEM Short Interest - Frequently Asked Questions What is Molecular Templates' current short interest? Short interest is the volume of Molecular Templates shares that have been sold short but have not yet been closed out or covered. As of December 15th, traders have sold 298,000 shares of MTEM short. 5.48% of Molecular Templates' shares are currently sold short. Learn More on Molecular Templates' current short interest. Which institutional investors are shorting Molecular Templates? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Molecular Templates: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Molecular Templates? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.48% of Molecular Templates' floating shares are currently sold short. Is Molecular Templates' short interest increasing or decreasing? Molecular Templates saw a increase in short interest in December. As of December 15th, there was short interest totaling 298,000 shares, an increase of 41.3% from the previous total of 210,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Molecular Templates' float size? Molecular Templates currently has issued a total of 6,580,000 shares. Some of Molecular Templates' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Molecular Templates currently has a public float of 5,440,000 shares. How does Molecular Templates' short interest compare to its competitors? 5.48% of Molecular Templates' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Molecular Templates: Amgen Inc. (2.38%), Vertex Pharmaceuticals Incorporated (1.78%), Gilead Sciences, Inc. (1.85%), Regeneron Pharmaceuticals, Inc. (2.00%), Alnylam Pharmaceuticals, Inc. (2.27%), Biogen Inc. (2.59%), United Therapeutics Co. (4.59%), Incyte Co. (3.06%), BioMarin Pharmaceutical Inc. (2.36%), Neurocrine Biosciences, Inc. (2.41%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.32 billion), Spotify Technology S.A. ($4.06 billion), Canadian Natural Resources Limited ($3.45 billion), Reddit, Inc. ($2.79 billion), International Paper ($2.70 billion), Cencora, Inc. ($2.27 billion), SoFi Technologies, Inc. ($2.21 billion), Lululemon Athletica Inc. ($2.13 billion), and Rivian Automotive, Inc. ($2.05 billion). View all of the most shorted stocks. What does it mean to sell short Molecular Templates stock? Short selling MTEM is an investing strategy that aims to generate trading profit from Molecular Templates as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Molecular Templates? A short squeeze for Molecular Templates occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MTEM, which in turn drives the price of the stock up even further. How often is Molecular Templates' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MTEM, twice per month. The most recent reporting period available is December, 15 2024. More Short Interest Resources from MarketBeat Related Companies Amgen Short Squeeze Vertex Pharmaceuticals Short Squeeze Gilead Sciences Short Squeeze Regeneron Pharmaceuticals Short Squeeze Alnylam Pharmaceuticals Short Squeeze Biogen Short Squeeze United Therapeutics Short Squeeze Incyte Short Squeeze BioMarin Pharmaceutical Short Squeeze Neurocrine Biosciences Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MTEM) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Molecular Templates, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Molecular Templates With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
